RGEN

#3802
Repligen Corporation - Common Stock
1.2 4 USD
-98.99%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.24
1.24
Intervallo Annuale
1.12
175.57
Variazione giornaliera
-98.99%
Variazione Mensile
-98.91%
Variazione di 6 mesi
-99.26%
Variazione Annuale
-99.25%
Chiusura Precedente
122.7 3
Open
1.2 4
Minimo
1.2 4
High
1.2 4
Volume
154
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 69.92 M
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Strumenti e Forniture Mediche
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
190.53
Rapporto prezzo/fatturato
0.01

Repligen Corporation - Common Stock

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Notizie